Skip to main content
SpringerLink
Log in

La modalità di preparazione a radioiodio non influenza la sopravvivenza nel carcinoma tiroideo metastatico

  • NOVITÀ IN ENDOCRINOLOGIA
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliografia

  1. Tala H, Robbins R, Fagin JA et al. (2011) Five-year survival is similar in thyroid cancer patients with distant metastases prepared for radioactive iodine therapy with either thyroid hormone withdrawal or recombinant human TSH. J Clin Endocrinol Metab 96(7):2105–2111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Campopiano MC, Podestà D, Bianchi F et al. (2020) No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH. Eur J Endocrinol 183(4):411–417

    Article  CAS  PubMed  Google Scholar 

  3. Klubo-Gwiezdzinska J, Burman KD, van Nostrand D et al. (2012) Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin. Thyroid 22(3):310–317

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Jarząb B, Handkiewicz-Junak D, Roskosz J et al. (2003) Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients. Eur J Nucl Med Mol Imaging 30(8):1077–1086

    Article  PubMed  Google Scholar 

  5. Haugen BR, Alexander EK, Bible KC et al. (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26(1):1–133

    Article  PubMed  PubMed Central  Google Scholar 

  6. Pötzi C, Moameni A, Karanikas G et al. (2006) Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients. Clin Endocrinol (Oxf) 65(4):519–523

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unità di Endocrinologia, Diabetologia e Andrologia Medica, IRCCS Istituto Clinico Humanitas, Rozzano, MI, Italia

    Salvatore Andrea Ariano & Andrea Lania

  2. Dipartimento di Scienze Biomediche, Humanitas University, Pieve Emanuele, MI, Italia

    Salvatore Andrea Ariano & Andrea Lania

Authors
  1. Salvatore Andrea Ariano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea Lania
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Salvatore Andrea Ariano.

Ethics declarations

Competing Interests

The authors declare no competing interests.

Additional information

Nota della casa editrice

Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ariano, S.A., Lania, A. La modalità di preparazione a radioiodio non influenza la sopravvivenza nel carcinoma tiroideo metastatico. L'Endocrinologo 24, 99–100 (2023). https://doi.org/10.1007/s40619-023-01217-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-023-01217-6

Search

Navigation